HR-LCMS/MS-Based Discovery of Plant Autophagy Inducers: Astragalus dasyanthus and Glabrol

Study Background and Research Question

Autophagy is a fundamental cellular process responsible for the degradation and recycling of defective organelles and proteins, playing a pivotal role in maintaining cellular homeostasis and preventing age-related diseases. Dysregulation of autophagy is implicated in conditions such as diabetes, atherosclerosis, and neurodegenerative diseases like Alzheimer's and Parkinson's. Given its importance, the search for novel autophagy activators—particularly from natural sources—remains a promising therapeutic strategy. Medicinal plants, long used in traditional medicine, are rich sources of bioactive metabolites; however, the identification of their active compounds remains challenging due to complex phytochemical profiles and variability caused by plant part, development stage, and geographic origin. Addressing this challenge, the study by Bolikhova et al. sought to develop and validate a rapid, effective workflow for identifying autophagy-inducing compounds from multicomponent plant extracts using high-resolution liquid chromatography–mass spectrometry (HR-LCMS/MS) (Bolikhova et al., 2026).

Key Innovation from the Reference Study

The central innovation of the study is the integration of a simplified HR-LCMS/MS-based dereplication strategy with bioactivity-guided fractionation, enabling rapid identification of principal autophagy inducers from complex plant extracts. Notably, this method led to the identification of Astragalus dasyanthus as a previously unrecognized source of glabrol, a flavonoid linked to autophagy activation. This finding not only expands the pharmacological potential of Astragalus dasyanthus but also demonstrates the utility of the workflow in accelerating the discovery of bioactive metabolites relevant to metabolic regulation and neurodegenerative disease research.

Methods and Experimental Design Insights

The workflow began with the preparation of ethanolic extracts from a panel of medicinal plants, selected based on their traditional usage and reported or suspected autophagy-modulating activity. The human neuroblastoma cell line SH-SY5Y was employed as a model system, given its widespread use in autophagy and neuroprotection studies. Extracts were screened for autophagy-inducing potential via Western blot analysis of LC3 I/II levels, a well-established marker of autophagic flux.

Extracts demonstrating autophagy activation were subjected to chromatographic fractionation (HPLC). Each fraction was again tested for activity in the SH-SY5Y assay, ensuring that only bioactive fractions advanced. These were then analyzed by HR-LCMS/MS to determine their chemical profiles. The critical step of dereplication—identifying known compounds within these active fractions—allowed the researchers to rapidly pinpoint candidate molecules responsible for the observed bioactivity without the need for complete de novo structure elucidation.

Core Findings and Why They Matter

The HR-LCMS/MS-based approach successfully identified the main autophagy-inducing compounds in extracts from five different plants. Most notably, the workflow revealed that Astragalus dasyanthus produces glabrol, a flavonoid not previously associated with this species, and established glabrol as the principal agent responsible for the plant's autophagy-inducing effect. This is significant for several reasons:

• Novelty: The identification of Astragalus dasyanthus as a new glabrol source broadens the available pool of plant-derived autophagy modulators, which is vital for drug discovery efforts targeting metabolic and neurodegenerative disorders.
• Methodological Efficiency: The streamlined dereplication workflow allows for high-throughput, evidence-based screening of complex plant matrices, which is often a bottleneck in natural product research.
• Pathway Relevance: By targeting autophagy, and specifically mitophagy (the clearance of damaged mitochondria), this approach directly intersects with mitochondrial biology research and metabolic regulation studies, areas increasingly linked to age-related pathologies and cancer biology.

These findings underscore the importance of robust analytical pipelines for harnessing the therapeutic potential of plant metabolites and provide a model for future investigations into the molecular mechanisms underlying traditional medicinal practices.

Comparison with Existing Internal Articles

Related internal resources, such as the article "HR-LCMS/MS Uncovers Glabrol as Autophagy Inducer in Astragalus dasyanthus", reinforce the value of HR-LCMS/MS workflows for rapid bioactive compound identification. Both highlight the scalability of this approach for broader metabolic and neurodegeneration research.

Furthermore, several internal articles review the use of mitochondrial uncouplers like FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) for dissecting cellular energy metabolism and hypoxia signaling in cancer research targeting HIF and VEGF pathways. For example, "FCCP: Advancing Immunometabolic Targeting for Translational Success" details the utility of FCCP in modulating mitochondrial function and inhibiting the hypoxia-inducible factor (HIF) pathway, which is mechanistically related to mitophagy and autophagy as explored in the reference study. This cross-comparison highlights how both plant-derived and chemical tools are instrumental in advancing mitochondrial biology research.

Limitations and Transferability

While the HR-LCMS/MS-based dereplication workflow proved effective in this study, several limitations should be acknowledged. Firstly, the method relies on the availability of comprehensive mass spectral libraries; novel or rare compounds without reference spectra may evade detection. Secondly, the use of a single cell line (SH-SY5Y) may limit the generalizability of the findings to other cell types or in vivo contexts. Thirdly, the study's focus on ethanolic extracts may miss bioactives present only in other solvent fractions. Finally, the biological relevance of glabrol and other identified compounds warrants further investigation in animal models to clarify their therapeutic potential and safety profiles.

Protocol Parameters

• Plant Extract Preparation: Ethanolic extraction from dried plant material; maceration times and ratios adjusted depending on plant type.
• Cell Line and Assay: SH-SY5Y neuroblastoma cells; Western blot detection of LC3 I/II levels to quantify autophagy induction.
• Fractionation: Preparative HPLC used to separate active extract fractions.
• Dereplication: HR-LCMS/MS performed on active fractions; dereplication through comparison to validated mass spectral libraries.
• Bioactivity-Guided Tracking: Each HPLC fraction is individually tested for autophagy activity prior to chemical profiling.

Research Support Resources

For researchers aiming to dissect mitochondrial function, autophagy, or the inhibition of hypoxia-inducible factor (HIF) pathways in cell culture models, chemical tools such as FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) (SKU B5004; APExBIO) offer a reproducible means to uncouple oxidative phosphorylation and model metabolic stress responses. FCCP’s application in mitochondrial biology research complements plant-derived strategies by enabling precise modulation of mitochondrial membrane potential, thereby supporting studies on autophagy, metabolic regulation, and the regulation of HIF/VEGF signaling. As always, FCCP is intended for research use only and should be handled according to established safety protocols.